8-methoxy-6-methyl-1,2,3,4-tetrahydro-1,7-naphthyridine, 95.0%, 500mg

(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-cyclohexylbutanoic acid, 97%, 25g

4-((5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)methyl)morpholine, 95.0%, 100mg

2-Amino-5-bromo-3-benzyloxypyridine, 95.0%, 5g

1-(4-Isopropyl-phenyl)-propan-1-one, 95.0%, 5g

3,4-DIFLUORO-4-METHYLPIPERIDINE, 95.0%, 250mg

tert-Butyl 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)azetidine-1-carboxylate, 97%, 5g

3-Bromo-4-methyl-1H-pyrrolo[2,3-b]pyridine, 98%, 250mg

4-Isopropyl-2-methylpyrimidine-5-carboxylic acid, 95%, 1g

tert-Butyl 4-hydroxy-4-(hydroxymethyl)piperidine-1-carboxylate, 95.0%, 250mg

Balofloxacin Dihydrate>98.0%(HPLC)(T)1g

Magnetic bar ejector ROTILABO®, 350 mm, 1 piece

3-Chloro-4-sulfanylbenzoic acid, 95%, 1g